Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Xpress Biologics

Xpress Biologics
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$715K LATEST DEAL AMOUNT
2 INVESTORS
Description

Operator of a contract manufacturing organization designed to provide services for pre-clinical productions. The company's manufacturing organization provides contract services for the production of recombinant proteins, antibody fragments and plasmid DNA, enabling the vaccine, therapeutic and diagnostic markets to execute and manage clinical trials.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • Accessia Pharma site
  • Avenue du Parc Industriel, 89, Milmort
  • 4041 Herstal
  • Belgium

+32 04 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Xpress Biologics’s full profile, request a free trial.

Xpress Biologics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 22-Dec-2016 $715K 00.000 00.000 Completed Generating Revenue
2. Early Stage VC 14-Aug-2015 00000 00000 00000 Completed Generating Revenue
1. Accelerator/Incubator 01-Feb-2013 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Xpress Biologics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Class C 0,000 0000.00 0000.00 00 0000.00 00.000
Class B 0,000 0000.00 0000.00 00 0000.00 00.000
Class A 000 0000.00 0000.00 00 0000.00 0.000
Class C 000 0000.00 0000.00 00 0000.00 0.000
Class B 1,300 $105.64 $105.64 1x $105.64 9.26%
Class A 1,211 $105.64 $105.64 1x $105.64 8.63%
To view this company’s complete Cap Table, request access »

Xpress Biologics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Noshaq Venture Capital Minority 000 0000 000000 0
WBC Accelerator/Incubator Minority 000 0000 000000 0

Xpress Biologics Executive Team (3)

Name Title Board
Seat
Contact
Info
Marc Daukandt Co-Founder, Executive Director & Chief Executive Officer
Philippe Ledent Ph.D Board Member & Scientific Director
Christian Rodriguez Ph.D Co-Founder, Operation Director & Board Member

Xpress Biologics Board Members (2)

Name Representing Role Since Contact
Info
Christian Rodriguez Ph.D Xpress Biologics Co-Founder, Operation Director & Board Member 000 0000
Philippe Ledent Ph.D Xpress Biologics Board Member & Scientific Director 000 0000